Advanced Search

Pathology/Lab Coding Alert

Path/Lab Coding:

Go Unlisted for Single NGS Multiple Gene Analysis

Published on Tue Dec 09, 2025

Question: A provider ordered a full gene sequence analysis of BRCA2 plus a BRCA1 known familial variant for the patient. We performed the testing using next generation sequencing (NGS). Should we bill this as 81163? Oklahoma Subscriber Answer: No, you should not report 81163 (BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Pathology/Lab Coding Alert